Sunesis Pharmaceuticals (SNSS)

Add to Watchlists
Create an Alert
2.58 +0.02  +0.78% NASDAQ Dec 18, 1:22PM BATS Real time Currency in USD

Sunesis Pharmaceuticals Debt to Equity Ratio (Quarterly):

3.201 for Sept. 30, 2014

View 4,000+ financial data types

View Full Chart

Sunesis Pharmaceuticals Debt to Equity Ratio (Quarterly) Chart

Export Data
Save Image

Sunesis Pharmaceuticals Historical Debt to Equity Ratio (Quarterly) Data

View and export this data going back to 2005. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Sept. 30, 2014 3.201
June 30, 2014 0.8717
March 31, 2014 0.6196
Dec. 31, 2013 -2.918
Sept. 30, 2013 -3.470
June 30, 2013 -3.799
March 31, 2013 21.60
Dec. 31, 2012 2.029
Sept. 30, 2012 2.407
June 30, 2012 1.358
March 31, 2012 0.6501
Dec. 31, 2011 0.3374
Sept. 30, 2011
June 30, 2011
March 31, 2011
Dec. 31, 2010
Sept. 30, 2010
June 30, 2010
March 31, 2010
   
Dec. 31, 2009
Sept. 30, 2009
June 30, 2009
March 31, 2009 0.00
Dec. 31, 2008 0.00
Sept. 30, 2008 0.1196
June 30, 2008 0.0906
March 31, 2008 0.0631
Dec. 31, 2007 0.0557
Sept. 30, 2007 0.0459
June 30, 2007 0.0378
March 31, 2007 0.038
Dec. 31, 2006 0.0324
Sept. 30, 2006 0.027
June 30, 2006 0.0274
March 31, 2006 0.0267
Dec. 31, 2005 0.0617
Sept. 30, 2005 0.0576
June 30, 2005 -0.0591

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Debt to Equity Ratio

Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.

A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.

It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More

Get data for
Advertisement

SNSS Debt to Equity Ratio (Quarterly) Benchmarks

Companies
Alcobra
Durata Therapeutics -4.042
Amicus Therapeutics 0.3305

SNSS Debt to Equity Ratio (Quarterly) Range, Past 5 Years

Minimum -3.799 Jun 2013
Maximum 21.60 Mar 2013
Average 1.907

SNSS Debt to Equity Ratio (Quarterly) Excel Add-In Codes

  • Metric Code: debt_equity_ratio
  • Latest data point: =YCP("SNSS", "debt_equity_ratio")
  • Last 5 data points: =YCS("SNSS", "debt_equity_ratio", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.